Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
PaperCitations, authors & open-access status
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,405 citations, 2009 year and green oa status.
1,405
Citations
2009
Year
green
OA Status